Synopsis
Synopsis
0
CEP/COS
0
KDMF
0
VMF
0
FDF
0
FDA Orange Book
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Pursennid
2. Senna Glycoside
3. Sennoside A And B
4. Sennoside A And B, Calcium Salt
5. Sennoside A Calcium
6. Sennoside A Calcium And Sennoside B Calcium
7. Sennoside A+b Calcium
8. Sennoside A, Calcium Salt
9. Sennoside A, Calcium Salt (1:1)
10. Sennoside B Calcium
11. Sennoside B, Calcium Salt
12. Sennosides
13. Sennosides A And B
14. Sennosides A And B Acids
15. Senokot
1. Sennoside G
2. Pursennid (tn)
3. Sennosides (usp)
4. 66575-30-2
5. Senna-lax
6. Sennoside A&b
7. 9-[2-carboxy-4-hydroxy-10-oxo-5-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-9h-anthracen-9-yl]-4-hydroxy-10-oxo-5-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-9h-anthracene-2-carboxylic Acid
8. 517-43-1
9. Sennoside (jan)
10. Sennoside A1
11. Sennoside A1 , Hplc Grade
12. Schembl11140501
13. Chebi:34974
14. (9,9'-bianthracene)-2,2'-dicarboxylic Acid, 5,5'-bis(beta-d-glucopyranosyloxy)-9,9',10,10'-tetrahydro-4,4'-dihydroxy-10,10'-dioxo-, (r*,r*)-
15. Mfcd32068370
16. D02171
17. 135s582
18. Q27116343
19. [9,9'-bianthracene]-2,2'-dicarboxylic Acid, 5,5'-bis(.beta.-d-glucopyranosyloxy)-9,9',10,10'-tetrahydro-4,4'-dihydroxy-10,10'-dioxo-, (9r,9's)-
20. 5,5'-bis(beta-d-glucopyranosyloxy)-4,4'-dihydroxy-10,10'-dioxo-9,9',10,10'-tetrahydro-9,9'-bianthracene-2,2'-dicarboxylic Acid
21. 5,5'-bis(beta-d-glucopyranosyloxy)-9,9',10,10'-tetrahydro-4,4'-dihydroxy-10,10'-dioxo-9,9'-bianthracene-2,2'-dicarboxylic Acid
22. 9-[2-carboxy-4-hydroxy-10-oxo-5-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-9h-anthracen-9-yl]-4-hydroxy-10-oxo-5-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-9h-anthracene-2-carboxylic Acid
Molecular Weight | 862.7 g/mol |
---|---|
Molecular Formula | C42H38O20 |
XLogP3 | 1.2 |
Hydrogen Bond Donor Count | 12 |
Hydrogen Bond Acceptor Count | 20 |
Rotatable Bond Count | 9 |
Exact Mass | 862.19564360 g/mol |
Monoisotopic Mass | 862.19564360 g/mol |
Topological Polar Surface Area | 348 Ų |
Heavy Atom Count | 62 |
Formal Charge | 0 |
Complexity | 1550 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 10 |
Undefined Atom Stereocenter Count | 2 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Laxatives
Agents that produce a soft formed stool, and relax and loosen the bowels, typically used over a protracted period, to relieve CONSTIPATION. (See all compounds classified as Laxatives.)
Alchem offers Phytochemical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.
Registration Number : 227MF10003
Registrant's Address : 201,Empire Plaza,Mehrauli-Gurgaon Road Sultanpur,New Delhi-110 030,INDIA
Initial Date of Registration : 2015-01-05
Latest Date of Registration : --
NDC Package Code : 55742-007
Start Marketing Date : 2012-05-31
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Alchem offers Phytochemical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.
Registration Number : 225MF10137
Registrant's Address : 201,Empire Plaza,Mehrauli-Gurgaon Road Sultanpur,New Delhi-110 030,INDIA
Initial Date of Registration : 2013-07-23
Latest Date of Registration : --
NDC Package Code : 55742-007
Start Marketing Date : 2012-05-31
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Alchem offers Phytochemical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.
Registration Number : 219MF10246
Registrant's Address : 301,Avalon Apartments,Mehrauli-Gurgaon Road Manglapuri,New Delhi-110 030,INDIA
Initial Date of Registration : 2007-07-17
Latest Date of Registration : --
NDC Package Code : 55742-007
Start Marketing Date : 2012-05-31
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 32508
Submission : 2018-01-29
Status : Active
Type : II
NDC Package Code : 52537-001
Start Marketing Date : 2012-12-19
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 32164
Submission : 2017-11-27
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 29523
Submission : 2015-06-11
Status : Inactive
Type : II
Date of Issue : 2022-01-04
Valid Till : 2025-02-01
Written Confirmation Number : WC-0350
Address of the Firm :
NDC Package Code : 55977-100
Start Marketing Date : 1996-10-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13991
Submission : 1999-02-23
Status : Inactive
Type : II
NDC Package Code : 17353-0902
Start Marketing Date : 2013-09-03
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : DRUG FOR FURTHER PROCESSING
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 14132
Submission : 1999-05-01
Status : Inactive
Type : II
NDC Package Code : 17353-0902
Start Marketing Date : 2013-09-03
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : DRUG FOR FURTHER PROCESSING
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ANALYTICAL
ABOUT THIS PAGE
A Sennosides manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Sennosides, including repackagers and relabelers. The FDA regulates Sennosides manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Sennosides API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Sennosides manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Sennosides supplier is an individual or a company that provides Sennosides active pharmaceutical ingredient (API) or Sennosides finished formulations upon request. The Sennosides suppliers may include Sennosides API manufacturers, exporters, distributors and traders.
click here to find a list of Sennosides suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Sennosides DMF (Drug Master File) is a document detailing the whole manufacturing process of Sennosides active pharmaceutical ingredient (API) in detail. Different forms of Sennosides DMFs exist exist since differing nations have different regulations, such as Sennosides USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Sennosides DMF submitted to regulatory agencies in the US is known as a USDMF. Sennosides USDMF includes data on Sennosides's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Sennosides USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Sennosides suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Sennosides Drug Master File in Japan (Sennosides JDMF) empowers Sennosides API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Sennosides JDMF during the approval evaluation for pharmaceutical products. At the time of Sennosides JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Sennosides suppliers with JDMF on PharmaCompass.
A Sennosides written confirmation (Sennosides WC) is an official document issued by a regulatory agency to a Sennosides manufacturer, verifying that the manufacturing facility of a Sennosides active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Sennosides APIs or Sennosides finished pharmaceutical products to another nation, regulatory agencies frequently require a Sennosides WC (written confirmation) as part of the regulatory process.
click here to find a list of Sennosides suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Sennosides as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Sennosides API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Sennosides as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Sennosides and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Sennosides NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Sennosides suppliers with NDC on PharmaCompass.
Sennosides Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Sennosides GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Sennosides GMP manufacturer or Sennosides GMP API supplier for your needs.
A Sennosides CoA (Certificate of Analysis) is a formal document that attests to Sennosides's compliance with Sennosides specifications and serves as a tool for batch-level quality control.
Sennosides CoA mostly includes findings from lab analyses of a specific batch. For each Sennosides CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Sennosides may be tested according to a variety of international standards, such as European Pharmacopoeia (Sennosides EP), Sennosides JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Sennosides USP).
LOOKING FOR A SUPPLIER?